Do doctors and patients know the risks? survey checks MS drug safety knowledge
NCT ID NCT05301907
Summary
This study was a survey to see if doctors, nurses, and patients with multiple sclerosis (MS) received and understood important safety information about the drug Mayzent. It involved 335 healthcare professionals and patients/caregivers in several European countries and Canada. The goal was to measure their knowledge about how to start the drug safely and manage specific risks like heart issues and infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Basel, Switzerland
Conditions
Explore the condition pages connected to this study.